BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7910069)

  • 1. Plasma PTH and PTH-rP levels and clodronate therapy in cancer patients with hypercalcemia.
    Su RJ; Chang CC; Tsai KS
    J Formos Med Assoc; 1993 Nov; 92(11):977-82. PubMed ID: 7910069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
    Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
    J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of the parathyrin-related protein (PTH-RP) in the diagnosis of cancer-associated hypercalcemia].
    Sagarra E; Villabona C; Bonnin R; Moliner R; Merino FJ; Sahún M; Soler J
    Med Clin (Barc); 1995 Oct; 105(12):450-4. PubMed ID: 7490935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate.
    Wimalawansa SJ
    Cancer; 1994 Apr; 73(8):2223-30. PubMed ID: 8156530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone-related protein and hypercalcemia.
    Rankin W; Grill V; Martin TJ
    Cancer; 1997 Oct; 80(8 Suppl):1564-71. PubMed ID: 9362423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemic complication in patients with oral squamous cell carcinoma.
    Iwase M; Takemi T; Manabe M; Nagumo M
    Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent hypercalcemia due to ectopic production of parathyroid hormone-related protein and intact parathyroid hormone in a single patient with multiple malignancies.
    Eid W; Wheeler TM; Sharma MD
    Endocr Pract; 2004; 10(2):125-8. PubMed ID: 15256329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of malignancy-associated hypercalcemia with YM175, a new bisphosphonate: elevated threshold for parathyroid hormone secretion in hypercalcemic patients.
    Fukumoto S; Matsumoto T; Takebe K; Onaya T; Eto S; Nawata H; Ogata E
    J Clin Endocrinol Metab; 1994 Jul; 79(1):165-70. PubMed ID: 8027221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
    Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
    J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
    Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of tumor hypercalcemia with clodronate.
    Ziegler R; Scharla SH
    Recent Results Cancer Res; 1989; 116():46-53. PubMed ID: 2527400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified immunoradiometric assay of parathyroid hormone-related protein: clinical application in the differential diagnosis of hypercalcemia.
    Pandian MR; Morgan CH; Carlton E; Segre GV
    Clin Chem; 1992 Feb; 38(2):282-8. PubMed ID: 1371724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
    Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
    J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating PTHrP concentrations in tumor-induced hypercalcemia: influence on the response to bisphosphonate and changes after therapy.
    Body JJ; Dumon JC; Thirion M; Cleeren A
    J Bone Miner Res; 1993 Jun; 8(6):701-6. PubMed ID: 8328312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma.
    Horiuchi T; Miyachi T; Arai T; Nakamura T; Mori M; Ito H
    Horm Metab Res; 1997 Sep; 29(9):469-71. PubMed ID: 9370119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chinese hamster ovarian cells transfected with human parathyroid hormone-related protein cDNA cause hypercalcemia in nude mice.
    Guise TA; Chirgwin JM; Favarato G; Boyce BF; Mundy GR
    Lab Invest; 1992 Oct; 67(4):477-85. PubMed ID: 1434529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia.
    Hiraki A; Ueoka H; Bessho A; Segawa Y; Takigawa N; Kiura K; Eguchi K; Yoneda T; Tanimoto M; Harada M
    Cancer; 2002 Oct; 95(8):1706-13. PubMed ID: 12365018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism.
    Firek AF; Kao PC; Heath H
    J Clin Endocrinol Metab; 1991 Mar; 72(3):541-6. PubMed ID: 1997510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of parathyroid hormone secretion during correction of tumor-associated hypercalcemia.
    Body JJ; Dumon JC; Seraj F; Cleeren A
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1385-8. PubMed ID: 1592885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of tumor hypercalcemia with clodronate. Effect on parathormone and calcitriol].
    Scharla SH; Minne HW; Sattar P; Mende U; Blind E; Schmidt-Gayk H; Wüster C; Ho T; Ziegler R
    Dtsch Med Wochenschr; 1987 Jul; 112(28-29):1121-5. PubMed ID: 2956079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.